Filing Details

Accession Number:
0001209191-14-012771
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-21 07:01:09
Reporting Period:
2014-02-20
Filing Date:
2014-02-21
Accepted Time:
2014-02-21 07:01:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI Pharmaceutical Preparations (2834) 352089858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301715 A Mark Sirgo C/O Biodelivery Sciences Intl, Inc.,
801 Corporate Center Drive, Suite 210
Raleigh NC 27607
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-20 140,000 $8.90 955,250 No 4 A Direct
Common Stock Disposition 2014-02-20 42,000 $8.92 913,250 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. The shares of common stock reported on this Form 4 were acquired by the Reporting Person as a result of the vesting of one-third units under a previous Restricted Stock Unit grant.
  2. The sale of the shares of common stock was made pursuant to a pre-planned 10b5-1 plan.
  3. On February 20, 2014, the Reporting Person sold an aggregate of 42,000 shares of the Issuer's Common Stock at a weighted average price of $8.92. The highest sale price for the Common Stock was $9.06 per share and the lowest sale price was $8.73 per share.